| Q36772208 | A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma |
| Q38688031 | A new insight on reciprocal relationship between microRNA expression and epigenetic modifications in human lung cancer. |
| Q33869822 | A ten-microRNA expression signature predicts survival in glioblastoma |
| Q34247366 | A unique combination of male germ cell miRNAs coordinates gonocyte differentiation |
| Q35671176 | Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas |
| Q28388180 | An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma |
| Q34064494 | An integrated analysis of miRNA and mRNA expressions in non-small cell lung cancers |
| Q37328637 | Analysis of microRNAs expressions in chondrosarcoma |
| Q35556517 | Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin Chemosensitivity |
| Q37046454 | BAP1 suppresses lung cancer progression and is inhibited by miR-31 |
| Q39394724 | Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells |
| Q21266711 | Characterisation and expression of microRNAs in developing wings of the neotropical butterfly Heliconius melpomene |
| Q38500323 | Cholinesterase-Targeting microRNAs Identified in silico Affect Specific Biological Processes |
| Q33737442 | Cigarette smoke induces C/EBP-β-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells |
| Q36638089 | Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis |
| Q35137739 | Clinical Significance of MicroRNA Expression Profiles and Polymorphisms in Lung Cancer Development and Management. |
| Q27345462 | Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities |
| Q37093273 | Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer |
| Q36130078 | Coordinated effects of microRNA-494 induce G₂/M arrest in human cholangiocarcinoma |
| Q39038455 | Crosstalk between Hippo signalling and miRNAs in tumour progression |
| Q34679234 | Cyclin E transgenic mice: discovery tools for lung cancer biology, therapy, and prevention |
| Q51119632 | Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer. |
| Q34342297 | Dicer-dependent biogenesis of small RNAs derived from 7SL RNA. |
| Q44415419 | Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung: results of a profiling study. |
| Q35391765 | Differentially expressed microRNAs in postpartum breast cancer in Hispanic women |
| Q37998154 | Distinctive microRNAs in esophageal tumor: early diagnosis, prognosis judgment, and tumor treatment |
| Q37392777 | Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2. |
| Q47101112 | Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma |
| Q36166856 | Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer |
| Q36500050 | Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2D |
| Q36446991 | Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer |
| Q46434900 | Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma. |
| Q34208077 | EGF up-regulates miR-31 through the C/EBPβ signal cascade in oral carcinoma |
| Q36525459 | Effective capture of circulating tumor cells from a transgenic mouse lung cancer model using dendrimer surfaces immobilized with anti-EGFR |
| Q35081153 | Elevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2 |
| Q37798947 | Epigenetic Alterations as Cancer Diagnostic, Prognostic, and Predictive Biomarkers |
| Q39227406 | Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression |
| Q53689237 | Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3. |
| Q37044144 | Evaluation of PPP2R2A as a prostate cancer susceptibility gene: a comprehensive germline and somatic study |
| Q48292871 | Evidence for a radiation-responsive 'p53 gateway' contributing significantly to the radioresistance of lepidopteran insect cells |
| Q36227333 | Evidence for microRNA-31 dependent Bim-Bax interaction preceding mitochondrial Bax translocation during radiation-induced apoptosis |
| Q34690600 | Evidence for tankyrases as antineoplastic targets in lung cancer. |
| Q36223149 | Evidence for the ubiquitin protease UBP43 as an antineoplastic target |
| Q41987857 | Expression and significance of circulating microRNA-31 in lung cancer patients |
| Q35576785 | Expression of dicer and its related miRNAs in the progression of prostate cancer |
| Q39269842 | Expression of miR-23a by apoptotic regulators in human cancer: A review |
| Q35799910 | Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence |
| Q35588532 | Fluorescence-based codetection with protein markers reveals distinct cellular compartments for altered MicroRNA expression in solid tumors |
| Q34043449 | From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies |
| Q38893973 | Function and regulation of microRNA-31 in development and disease. |
| Q37855515 | Genetic and epigenetic changes in lung carcinoma and their clinical implications |
| Q39285644 | Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma. |
| Q36557209 | HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma |
| Q41255588 | Identification of aminosulfonylarylisoxazole as microRNA-31 regulators. |
| Q87611226 | Identification of microRNAs as novel biomarkers for detecting esophageal squamous cell carcinoma in Asians: a meta-analysis |
| Q38430180 | Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles |
| Q37324829 | In Silico Study of miRNA Based Gene Regulation, Involved in Solid Cancer, by the Assistance of Argonaute Protein |
| Q38956930 | Induction of cancer-related microRNA expression profiling using excretory-secretory products of Clonorchis sinensis |
| Q36225884 | Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7. |
| Q35561695 | Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer |
| Q28530422 | Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer |
| Q34771731 | Involvement of microRNAs in lung cancer biology and therapy |
| Q55129896 | Is microRNA-31 a key regulator of breast tumorigenesis? |
| Q33112080 | Islet-1 is a dual regulator of fibrogenic epithelial-to-mesenchymal transition in epicardial mesothelial cells. |
| Q38969680 | K14-EGFP-miR-31 transgenic mice have high susceptibility to chemical-induced squamous cell tumorigenesis that is associating with Ku80 repression |
| Q38903950 | Keratin 17 is co-expressed with 14-3-3 sigma in oral carcinoma in situ and squamous cell carcinoma and modulates cell proliferation and size but not cell migration |
| Q38898420 | LATS2 induced by TNF-alpha and inhibited cell proliferation and invasion by phosphorylating YAP in oral squamous cell carcinoma |
| Q50053448 | LATS2 promoter hypermethylation and its effect on gene expression in human breast cancer. |
| Q97589690 | LINC00689 participates in proliferation, chemoresistance and metastasis via miR-31-5p/YAP/β-catenin axis in colorectal cancer |
| Q41018220 | Loss of RASSF1A synergizes with deregulated RUNX2 signaling in tumorigenesis |
| Q35207787 | Lung cancer and lung injury: the dual role of ceramide |
| Q34104798 | Lung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smoke |
| Q34432733 | Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor. |
| Q35072844 | MIR376A is a regulator of starvation-induced autophagy |
| Q37843031 | Mammalian Hippo pathway: from development to cancer and beyond |
| Q89967082 | Manipulating microRNAs for the Treatment of Malignant Pleural Mesothelioma: Past, Present and Future |
| Q55632252 | MiR-1256 suppresses proliferation and migration of non-small cell lung cancer via regulating TCTN1. |
| Q38952149 | MiR-136 modulates glioma cell sensitivity to temozolomide by targeting astrocyte elevated gene-1. |
| Q39613855 | MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2. |
| Q91975406 | MiR-222-3p in Platelets Serves as a Distinguishing Marker for Early Recognition of Kawasaki Disease |
| Q38998812 | MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A. |
| Q42380563 | MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists |
| Q47133718 | MiR-31-5p-ACOX1 Axis Enhances Tumorigenic Fitness in Oral Squamous Cell Carcinoma Via the Promigratory Prostaglandin E2. |
| Q89697494 | MiRNAs and LncRNAs: Dual Roles in TGF-β Signaling-Regulated Metastasis in Lung Cancer |
| Q37297742 | MiRNAs which target CD3 subunits could be potential biomarkers for cancers |
| Q38937055 | Micro RNAs: an arguable appraisal in medicine. |
| Q26771418 | Micro-Ribonucleic Acid and Carcinogenesis: Breast Cancer as an Example |
| Q64953093 | MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma. |
| Q37994747 | MicroRNA as a novel drug target for cancer therapy |
| Q39015995 | MicroRNA down-regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint. |
| Q39037653 | MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance |
| Q34256044 | MicroRNA in lung cancer |
| Q33748980 | MicroRNA profiles discriminate among colon cancer metastasis |
| Q35907409 | MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer |
| Q37869934 | MicroRNA profiling in cancer |
| Q35105405 | MicroRNA signatures differentiate Crohn's disease from ulcerative colitis |
| Q51711929 | MicroRNA, epigenetic machinery and lung cancer. |
| Q35757995 | MicroRNA-135b regulates apoptosis and chemoresistance in colorectal cancer by targeting large tumor suppressor kinase 2. |
| Q33989118 | MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China |
| Q38613683 | MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis |
| Q40714376 | MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer |
| Q36725131 | MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1). |
| Q86448439 | MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes |
| Q35781512 | MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer |
| Q38705662 | MicroRNA-31 functions as an oncogenic microRNA in cutaneous squamous cell carcinoma cells by targeting RhoTBT1. |
| Q38637829 | MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells |
| Q36430771 | MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer |
| Q35451400 | MicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cellular senescence |
| Q37295098 | MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma |
| Q49560601 | MicroRNA-31 promotes arterial smooth muscle cell proliferation and migration by targeting mitofusin-2 in arteriosclerosis obliterans of the lower extremitie |
| Q35604813 | MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2. |
| Q44848925 | MicroRNA-31 suppresses the self-renewal capability of α2δ1+ liver tumor-initiating cells by targeting ISL1. |
| Q51821489 | MicroRNA-31-5p modulates cell cycle by targeting human mutL homolog 1 in human cancer cells. |
| Q93017711 | MicroRNA-486-5p and microRNA-486-3p: Multifaceted pleiotropic mediators in oncological and non-oncological conditions |
| Q34169033 | MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2. |
| Q38522728 | MicroRNA: master controllers of intracellular signaling pathways |
| Q35704188 | MicroRNAome genome: a treasure for cancer diagnosis and therapy. |
| Q40575902 | MicroRNAs - Important Molecules in Lung Cancer Research |
| Q34158964 | MicroRNAs As Biomarkers For Clinical Features Of Lung Cancer |
| Q38005062 | MicroRNAs and lung cancers: from pathogenesis to clinical implications |
| Q57166469 | MicroRNAs and their role in environmental chemical carcinogenesis |
| Q35206847 | MicroRNAs as potential biomarkers for VERO cell tumorigenicity |
| Q28293733 | MicroRNAs as therapeutic targets for lung cancer |
| Q38261676 | MicroRNAs in lung cancer |
| Q28396395 | MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets |
| Q37679619 | MicroRNAs-role in lung cancer |
| Q37985756 | MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment |
| Q91994202 | Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer |
| Q47709456 | Modulation of oncogenic miRNA biogenesis using functionalized polyamines. |
| Q38309155 | New insights into lung development and diseases: the role of microRNAs. |
| Q38708974 | Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer |
| Q33648562 | Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance |
| Q38373911 | Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment |
| Q38834072 | Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells. |
| Q59491153 | Overexpression of SNORD114-3 marks acute promyelocytic leukemia |
| Q37507398 | PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer |
| Q34434075 | Patterns of microRNA expression in non-human primate cells correlate with neoplastic development in vitro |
| Q50056269 | Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers. |
| Q91798836 | Post-transcriptional regulation of PIAS3 expression by miR-18a in malignant mesothelioma |
| Q34425208 | Prenatal exposure to TCDD triggers significant modulation of microRNA expression profile in the thymus that affects consequent gene expression |
| Q41612865 | Prognostic microRNAs in upper tract urothelial carcinoma: multicenter and international validation study. |
| Q87621685 | Prognostic role of microRNA-31 in various cancers: a meta-analysis |
| Q37741183 | Proof-of-concept study: profile of circulating microRNAs in Bovine serum harvested during acute and persistent FMDV infection |
| Q35251561 | Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic |
| Q29392204 | RNA Interference and Cancer Therapy |
| Q38132299 | Regulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signalling |
| Q33889489 | Regulation of cancer aggressive features in melanoma cells by microRNAs |
| Q28072716 | Regulatory mechanisms of microRNAs in lung cancer stem cells |
| Q36361891 | Repression of Esophageal Neoplasia and Inflammatory Signaling by Anti-miR-31 Delivery In Vivo |
| Q93188625 | Repression of GCN5 expression or activity attenuates c-MYC expression in non-small cell lung cancer |
| Q28587965 | Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway |
| Q36643409 | Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations |
| Q37374960 | Role of MicroRNAs in lung disease |
| Q36503089 | Role of deregulated microRNAs in non-small cell lung cancer progression using fresh-frozen and formalin-fixed, paraffin-embedded samples. |
| Q38341378 | Roles of the Hippo pathway in lung development and tumorigenesis |
| Q35452140 | SATB1 and 2 in colorectal cancer |
| Q35218210 | SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells |
| Q50886835 | Serum microRNA-376 family as diagnostic and prognostic markers in human gliomas. |
| Q37107787 | Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo |
| Q38060071 | Small regulatory RNAs controlled by genomic imprinting and their contribution to human disease |
| Q39634084 | Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells |
| Q38841574 | Targeting the Wnt-Regulatory Protein CTNNBIP1 by microRNA-214 Enhances the Stemness and Self-Renewal of Cancer Stem-Like Cells in Lung Adenocarcinomas |
| Q37702220 | The ISG15-specific protease USP18 regulates stability of PTEN. |
| Q38370368 | The Interplay between PP2A and microRNAs in Leukemia |
| Q39394211 | The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway |
| Q34244270 | The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1 |
| Q34525363 | The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma |
| Q38133768 | The diverse role of miR-31 in regulating cancer associated phenotypes. |
| Q40191149 | The microRNA miR-31 inhibits CD8+ T cell function in chronic viral infection |
| Q35402507 | The microRNA-520a-3p inhibits proliferation, apoptosis and metastasis by targeting MAP3K2 in non-small cell lung cancer |
| Q28271675 | The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis |
| Q33754114 | The new concepts on overcoming drug resistance in lung cancer |
| Q54365633 | The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. |
| Q33734765 | The potential clinical applications and prospects of microRNAs in lung cancer |
| Q34194198 | The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells |
| Q37996436 | The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies. |
| Q30244001 | The roles of miRNAs as potential biomarkers in lung diseases |
| Q48251415 | Tissue and serum microRNA profile of oral squamous cell carcinoma patients. |
| Q89980713 | Tissue microRNAs in non-small cell lung cancer detected with a new kind of liquid bead array detection system |
| Q35190111 | Tissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine? |
| Q38805461 | Transcriptional Regulation of miR-31 by Oncogenic KRAS Mediates Metastatic Phenotypes by Repressing RASA1 |
| Q30543779 | Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties |
| Q54940097 | Upregulation of miR-614 promotes proliferation and inhibits apoptosis in ovarian cancer by suppressing PPP2R2A expression. |
| Q85892729 | Upregulation of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma with sarcomatoid component |
| Q33787405 | Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinoma |
| Q82893669 | [MicroRNAs as therapeutic targets for lung cancer] |
| Q89636813 | circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway |
| Q36983771 | miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer |
| Q49561776 | miR-136 targets MIEN1 and involves the metastasis of colon cancer by suppressing epithelial-to-mesenchymal transition |
| Q31139474 | miR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor |
| Q41461031 | miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1. |
| Q39166800 | miR-194 suppresses metastasis of non-small cell lung cancer through regulating expression of BMP1 and p27(kip1). |
| Q37204184 | miR-19a/b modulates lung cancer cells metastasis through suppression of MXD1 expression |
| Q35228579 | miR-203 suppresses the proliferation and migration and promotes the apoptosis of lung cancer cells by targeting SRC. |
| Q36375224 | miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer |
| Q34288764 | miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer |
| Q47119023 | miR-31 Functions as an Oncomir Which Promotes Epithelial-Mesenchymal Transition via Regulating BAP1 in Cervical Cancer. |
| Q34480433 | miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production |
| Q42146975 | miR-31 functions as an oncogene in cervical cancer |
| Q39028904 | miR-31 is upregulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes |
| Q64056244 | miR-31-5p Is a Potential Circulating Biomarker and Therapeutic Target for Oral Cancer |
| Q34640230 | miR-34 - a microRNA replacement therapy is headed to the clinic |
| Q90477959 | miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2 |
| Q39411578 | miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1. |
| Q49718872 | miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2. |
| Q38858548 | miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells |
| Q35907923 | miR-Sens--a retroviral dual-luciferase reporter to detect microRNA activity in primary cells |
| Q37940013 | miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer |
| Q38186130 | miRNA expression profiles associated with diagnosis and prognosis in lung cancer |
| Q38092617 | miRNA-Based Therapeutic Strategies |
| Q33792672 | microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway |
| Q38021509 | microRNA regulation of cell viability and drug sensitivity in lung cancer |
| Q34504964 | microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis |
| Q36383144 | microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (review). |
| Q38638204 | microRNAs: An Emerging Paradigm in Lung Cancer Chemoresistance |